129 related articles for article (PubMed ID: 9988877)
1. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study.
Mastroiacovo P; Mazzone T; Addis A; Elephant E; Carlier P; Vial T; Garbis H; Robert E; Bonati M; Ornoy A; Finardi A; Schaffer C; Caramelli L; Rodríguez-Pinilla E; Clementi M
Teratology; 1999 Jan; 59(1):7-11. PubMed ID: 9988877
[TBL] [Abstract][Full Text] [Related]
2. Teratogenicity of high vitamin A intake.
Rothman KJ; Moore LL; Singer MR; Nguyen US; Mannino S; Milunsky A
N Engl J Med; 1995 Nov; 333(21):1369-73. PubMed ID: 7477116
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
5. Prevention of congenital abnormalities by vitamin A.
Czeizel AE; Rockenbauer M
Int J Vitam Nutr Res; 1998; 68(4):219-31. PubMed ID: 9706496
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
7. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
[TBL] [Abstract][Full Text] [Related]
8. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome following use of large doses of vitamin B6 in the first trimester.
Shrim A; Boskovic R; Maltepe C; Navios Y; Garcia-Bournissen F; Koren G
J Obstet Gynaecol; 2006 Nov; 26(8):749-51. PubMed ID: 17130022
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular malformations among preterm infants.
Tanner K; Sabrine N; Wren C
Pediatrics; 2005 Dec; 116(6):e833-8. PubMed ID: 16322141
[TBL] [Abstract][Full Text] [Related]
11. Safety of vitamin A: recent results.
Wiegand UW; Hartmann S; Hummler H
Int J Vitam Nutr Res; 1998; 68(6):411-6. PubMed ID: 9857270
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of prenatal methimazole exposure.
Di Gianantonio E; Schaefer C; Mastroiacovo PP; Cournot MP; Benedicenti F; Reuvers M; Occupati B; Robert E; Bellemin B; Addis A; Arnon J; Clementi M
Teratology; 2001 Nov; 64(5):262-6. PubMed ID: 11745832
[TBL] [Abstract][Full Text] [Related]
13. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
14. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
Schaefer C; Hannemann D; Meister R
Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
[TBL] [Abstract][Full Text] [Related]
15. Bupropion in pregnancy and the prevalence of congenital malformations.
Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome of women exposed to azathioprine during pregnancy.
Goldstein LH; Dolinsky G; Greenberg R; Schaefer C; Cohen-Kerem R; Diav-Citrin O; Malm H; Reuvers-Lodewijks ME; Rost van Tonningen-van Driel MM; Arnon J; Ornoy A; Clementi M; Di Gianantonio E; Koren G; Braunstein R; Berkovitch M
Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):696-701. PubMed ID: 17847119
[TBL] [Abstract][Full Text] [Related]
18. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
Garlantézec R; Monfort C; Rouget F; Cordier S
Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
[TBL] [Abstract][Full Text] [Related]
19. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
